Search Results - "Cook, Chyung S"

Refine Results
  1. 1

    PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS by COOK, Chyung S, BERRY, Loren M, BIBLE, Roy H, HRIBAR, Jeremy D, HAJDU, Elisabeth, LIU, Norman W

    Published in Drug metabolism and disposition (01-11-2003)
    “…A pharmacokinetics and metabolism study was conducted in eight healthy human volunteers. After oral administration of [ 14 C]eplerenone (EP) at a dose of 100…”
    Get full text
    Journal Article
  2. 2

    Involvement of CYP3A in the Metabolism of Eplerenone in Humans and Dogs: Differential Metabolism by CYP3A4 and CYP3A5 by COOK, Chyung S, BERRY, Loren M, KIM, David H, BURTON, Earl G, HRIBAR, Jeremy D, ZHANG, Liming

    Published in Drug metabolism and disposition (01-12-2002)
    “…In vitro studies were conducted to identify the major metabolites of eplerenone (EP) and the cytochrome P450 (P450) isozymes involved in its primary oxidative…”
    Get full text
    Journal Article
  3. 3

    Involvement of Human UGT2B7 and 2B15 in Rofecoxib Metabolism by ZHANG, Ji Y, ZHAN, Jenny, COOK, Chyung S, INGS, Robert M, BREAU, Alan P

    Published in Drug metabolism and disposition (01-05-2003)
    “…O -Glucuronidation of 5-hydroxyrofecoxib is the major biotransformation pathway of rofecoxib in human, rat, and dog. The glucuronide conjugate is also involved…”
    Get full text
    Journal Article
  4. 4
  5. 5

    DIFFERENTIAL ENANTIOSELECTIVITY AND PRODUCT-DEPENDENT ACTIVATION AND INHIBITION IN METABOLISM OF VERAPAMIL BY HUMAN CYP3AS by LIXIN SHEN, FITZLOFF, John F, COOK, Chyung S

    Published in Drug metabolism and disposition (01-02-2004)
    “…In vitro studies of enantioselective metabolism of R -(+)- and S -(-)verapamil (VER) were conducted using human cDNA-expressed CYP3A isoforms, CYP3A4, CYP3A5,…”
    Get full text
    Journal Article
  6. 6

    Interconversion pharmacokinetics of eplerenone, a selective aldosterone blocker, and its lactone-ring open form by Cook, Chyung S, Zhang, Liming

    Published in Journal of pharmaceutical sciences (01-06-2002)
    “…The interconversion pharmacokinetics of eplerenone and its lactone-ring open form, SC-70303, were examined in dogs using a stable isotope method. [13CD3]EP and…”
    Get more information
    Journal Article
  7. 7

    Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption by Paulson, S K, Vaughn, M B, Jessen, S M, Lawal, Y, Gresk, C J, Yan, B, Maziasz, T J, Cook, C S, Karim, A

    “…Celecoxib pharmacokinetics was evaluated after single and multiple oral dosing; after dosing in a solution and as a solid; with and without food; and after…”
    Get more information
    Journal Article
  8. 8

    Atypical dose-route-dependent food effects of eplerenone in the dog: presence of food effects following intravenous dosing and lack of food effects of following oral dosing by Cook, Chyung S, Zhang, Liming

    Published in Journal of pharmaceutical sciences (01-03-2002)
    “…This study was conducted to investigate why a food effect was observed following an intravenous dose of eplerenone (EP) in the dog, but not following oral…”
    Get more information
    Journal Article
  9. 9

    Absorption and disposition of a selective aldosterone receptor antagonist, eplerenone, in the dog by COOK, Chyung S, LIMING ZHANG, FISCHER, Judee S

    Published in Pharmaceutical research (01-11-2000)
    “…The present study was conducted to characterize the pharmacokinetics of eplerenone (EP), a selective aldosterone receptor antagonist, and its open lactone ring…”
    Get full text
    Journal Article
  10. 10

    Eplerenone: a selective aldosterone receptor antagonist (SARA) by Delyani, J A, Rocha, R, Cook, C S, Tobert, D S, Levin, S, Roniker, B, Workman, D L, Sing, Y L, Whelihan, B

    Published in Cardiovascular drug reviews (01-09-2001)
    “…Aldosterone, the final product of the renin-angiotensin-aldosterone system (RAAS), is a mineralocorticoid hormone that classically acts, via the…”
    Get more information
    Journal Article
  11. 11

    Mechanism of compound- and species-specific food effects of structurally related antiarrhythmic drugs, disopyramide and bidisomide by COOK, C. S, LIMING ZHANG, OSIS, J, SCHOENHARD, G. L, KARIM, A

    Published in Pharmaceutical research (01-03-1998)
    “…To determine mechanism of food effects observed with bidisomide but not with the structurally similar drug, disopyramide. Food effect studies of bidisomide and…”
    Get full text
    Journal Article
  12. 12

    Mechanisms of food effects of structurally related antiarrhythmic drugs, disopyramide and bidisomide in the rat by LEE, K.-H, XU, G.-X, SCHOENHARD, G. L, COOK, C. S

    Published in Pharmaceutical research (01-08-1997)
    “…To determine whether the rat is a good animal model for the food effects observed with bidisomide but not with the structurally similar antiarrhythmic drug,…”
    Get full text
    Journal Article
  13. 13

    Effects of SC-56525, a Potent, Orally Active Renin Inhibitor, in Salt-Depleted and Renal Hypertensive Dogs by McMahon, Ellen G, Yang, Po-Chang, Babler, Maribeth A, Bittner, Stephen E, Suleymanov, Osman D, Cain-Janicki, Kimberly J, Bedell, Louis J, Hanson, Gunnar J, Cook, Chyung S

    Published in Hypertension (Dallas, Tex. 1979) (01-07-1995)
    “…SC-56525 is a nanomolar inhibitor of plasma renin activity in human, cynomolgus monkey, dog, guinea pig, Yucatan micropig, and rabbit but is less active in…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Species dependent esterase activities for hydrolysis of an anti-HIV prodrug glycovir and bioavailability of active SC-48334 by COOK, C. S, KARABATSOS, P. J, SCHOENHARD, G. L, KARIM, A

    Published in Pharmaceutical research (01-08-1995)
    “…The in vitro fate of an ester prodrug, glycovir, was studied to determine if the species differences in the bioavailability of pharmacologically active…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Effect of salicylic acid on the plasma protein binding and pharmacokinetics of misoprostol acid by Cook, C S, Schoenhard, G L, Karim, A

    Published in Journal of pharmaceutical sciences (01-06-1994)
    “…The in vitro serum protein binding and erythrocyte uptake of [3H]misoprostol acid ([3H]MPA; SC-30695), an active metabolite of the prostaglandin E1 (PGE1)…”
    Get more information
    Journal Article
  19. 19

    Pharmacokinetics of a novel antiarrhythmic drug, actisomide by COOK, C. S, ROZEK, L. F, STOLZENBACH, J, ANDERSON, S, SCHOENHARD, G. L, KARIM, A

    Published in Pharmaceutical research (01-03-1993)
    “…The pharmacokinetics of a novel antiarrhythmic drug, actisomide, were examined in the rat, dog, monkey, and human. The terminal half-life of actisomide was…”
    Get full text
    Journal Article
  20. 20